Study of Sodium Arsenite in Treating 30 Cases of Adult Chronic Myeloid Leukemia
- VernacularTitle:三氧化二砷治疗慢性粒细胞白血病临床研究
- Author:
Pu ZHAO
- Publication Type:Journal Article
- Keywords:
Chronic;
Leukemia mylocytic;
Sodium arsenite
- From:
Journal of Medical Research
2006;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To estimate the effect of sodium arsenite(AS2O3)in treating adult chronic myeloid leukemia(CML).Methods 30 inpatients diagnosed as CML from December 2002 to January 2008 were treated with AS2O3,of which 16 cases had not been treated previously,while 14 cases were relapsing or resistant to previous treatment.Results The complete response rate was 63.3%,while the partial response rate was 20.0%,non-response rate was 16.7%.The total response rate was 83.3%.Conclusion AS2O3 is an effective drug in treating CML with side effects being mild and well tolerance.
